Staying Healthy in a Time of COVID-19 (https://www.myeloma.org/blog/staying-healthy-time-covid-19)

Week in Review
young couple cooking in kitchen

April 22, 2021

For myeloma patients, staying healthy is an extra challenge as they focus on achieving response to treatments and sustaining remissions. The added burden of COVID-19 uncertainties is at times overwhelming. In an effort to build resilience it is helpful to take a step back and, especially on Earth Day (https://www.earthday.org/), think about the health of planet Earth, and everyone and everything living here. 

Eating healthy food 

On Earth Day we remember the power of biodiversity and the hard work needed to sustain the fragile balances in our environment.

The impact of vaccination 

Getting vaccinated is vital to re-entering the community. It is now becoming feasible for most patients with MGUS, SMM or active myeloma to be vaccinated. The widely available Pfizer or Moderna vaccines are preferentially recommended, if possible.

  • NEW REPORT DOCUMENTS ANTIBODY RESPONSES TO COVID-19 VACCINATION: Dr. Evangelos Terpos and his colleagues from the University of Athens, Greece summarized the antibody responses in elderly patients (median age 83 years) with smoldering or active myeloma (https://ashpublications.org/blood/article/doi/10.1182/blood.2021011904/475743/Low-Neutralizing-Antibody-Responses-Against-SARS). Antibody levels were checked 22 days after the first dose of the Pfizer vaccine. Obviously, two doses are recommended for full vaccination, so this study just assessed the early responses with the first dose. The active (inhibiting) antibody levels were 20.6% for myeloma patients versus 32.5% for normal controls overall. So, definitely, overall lower.

    Looking more specifically at a 30% level of antibodies, a target for Day 22, this was achieved by 25% of myeloma patients versus 54.8% controls. Again, lower. Excellent antibody levels of over 50% occurred in just 4 out of the 48 patients in this study. These patients were in remission and off therapy at the time. Thus, ongoing active therapy clearly reduced antibody levels achieved. The small numbers did not allow discrimination between different types of anti-myeloma therapy, although all patients on daratumumab containing regimens appeared to have especially low antibody levels.

    The lower antibody levels are not unexpected and appeared especially linked to low levels of normal immunoglobulins (IgG/IgA/IgM), “immunosuppression” in patients with both SMM and active MM. Of note, only 1 of 11 patients with SMM achieved antibody levels of over 30%. Thus, even in this patient group the immunosuppression contributes to suboptimal antibody responses.

    Much larger studies are now ongoing and will assess further vaccination doses and actual prevention of COVID-19 infections or lack of serious outcomes in the vaccinated patients. It is certainly hoped that despite suboptimal antibody responses the vaccinations will be helpful in producing improved outcomes.

Bottom line

Try hard to stay healthy and get vaccinated! In addition to eating healthy food, it’s important to get regular exercise (walking with family and/or friends) and maintain social connections via Zoom, phone or in outdoor, socially distanced settings. Staying connected is the key to maintaining day-to-day sanity while we await a return to normal.

Translations:

Arabic (https://www.myeloma.org/sites/default/files/Translations/Durie-Blog-042221-ARB.pdf)  Dutch (https://www.myeloma.org/sites/default/files/Translations/Durie-Blog-042221-DUTCH.pdf)  German (https://www.myeloma.org/sites/default/files/Translations/Durie-Blog-042221-GER.pdf)  Italian (https://www.myeloma.org/sites/default/files/Translations/Durie-Blog-042221-ITA.pdf)  Russian (https://www.myeloma.org/sites/default/files/Translations/Durie-Blog-042221-RUS.pdf)  Spanish (https://www.myeloma.org/sites/default/files/Translations/Durie-Blog-042221-ESP.pdf)


 


Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.


 


Source URL: https://www.myeloma.org/blog/staying-healthy-time-covid-19